Condition

Relapsed Multiple Myeloma clinical trials and research

• 5Clinical trials
• 2Countries

Newest Relapsed Multiple Myeloma clinical trials

All recruiting trials (5)

• Target IgG levels for people with multiple myeloma on BCMA-directed T-cell engager therapy

  This will test whether keeping IgG levels at 4–6 g/L works as well as 8–10 g/L to prevent severe infections in adults with relapsed or refractory multiple myeloma who are receiving BCMA-directed T-cell engager therapy.

  Recruiting at 2 sites Phase 4 CHU de Quebec-Universite Laval · Lévis, Quebec and 1 other locations · NCT07094048

• Assessing a new treatment for relapsed and refractory multiple myeloma

  This study is testing a new treatment called OPN-6602, alone and with another medication, to see if it can help people with relapsed or hard-to-treat multiple myeloma feel better and stay safe during the process.

  Recruiting at 12 sites Phase 1 Opna Bio LLC · Gilbert, Arizona and 11 other locations · NCT06433947

• Talquetamab combined with iberdomide and dexamethasone for relapsed or refractory multiple myeloma

  This phase 1 trial will test whether adding iberdomide and dexamethasone to talquetamab helps people with relapsed or refractory multiple myeloma who have already received proteasome inhibitors, immunomodulatory drugs, and CD38 antibodies.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT06348108

• IDP-023 treatment for advanced blood cancers

  This study is testing a new treatment called IDP-023, which uses special immune cells alone and with other medications to see if it can help people with advanced blood cancers like multiple myeloma and non-Hodgkin lymphoma.

  Recruiting at 9 sites Phase 1/2 Indapta Therapeutics, INC. · Los Angeles, California and 11 other locations · NCT06119685

• Combination therapy for relapsed or refractory multiple myeloma

  This study is testing a new combination of medications to see if it can help people with relapsed or refractory multiple myeloma feel better and improve their treatment results.

  Recruiting Phase 2 University of Miami · Miami, Florida · NCT05896228

Related topics

Quick answers

How many Relapsed Multiple Myeloma clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (4 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 4: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →